4th Quarter - Report

VIAL HEALTH TECHNOLOGY, INC. for VIAL HEALTH TECHNOLOGY, INC.

Firm
Client
Income
—
Expenses
$280,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Regulatory and policy issues related to drug development and clinical trials

LobbyistCovered position, as disclosed
PAOLO MASTRANGELO —

Contacted: Health & Human Services, Dept of (HHS); White House Office; Defense, Dept of (DOD); Executive Office of the President (EOP); Natl Institutes of Health (NIH); Vice President of the U.S.; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.